CAMBRIDGE, Mass., June 3, 2014 /PRNewswire/ -- The National Institute of Health has awarded a Phase I Small Business Innovation Research (SBIR) grant to Daktari Diagnostics for a point-of-care ...

Daktari Diagnostics closed a $15.5 million Series D round to support development of its innovative HIV test, chalking up a milestone in its quest to raise $30 million in funding for the product.

CAMBRIDGE, Mass., July 9, 2014 /PRNewswire/ -- Daktari Diagnostics is proud to support the African Society for Laboratory Medicine as the Strategic Partner Sponsor of ASLM's second international ...

Daktari Diagnostics Inc. pulled in $1.8 million, according to a Securities & Exchange Commission filing. The Cambridge, Mass.-based developer of a point-of-care HIV test raised the equity-based ...

Daktari Diagnostics Inc., which has developed a point-of-care HIV test aimed at guiding treatment decisions, said it has raised a $10 million funding round to bring its diagnostic products to ...

Merck & Co. will partner with Daktari Diagnostics to develop Daktari’s rapid hepatitis C virus (HCV) screening test, under a collaboration that will generate up to $8.5 million over three years ...

One of those challenges is expanding manufacturing capacity for its HIV test. In April 2013, Daktari announced that it would spend $15 million to build a plant in Scotland to manufacture its point ...